Article Versions Notes

François-Martin H, Lardy-Cléaud A, Pistilli B, Levy C, Diéras V, Frenel J-S, Guiu S, Mouret-Reynier M-A, Mailliez A, Eymard J-C, et al. Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study. Cancers. 2023; 15(4):1191. https://doi.org/10.3390/cancers15041191

François-Martin, Hélène, Audrey Lardy-Cléaud, Barbara Pistilli, Christelle Levy, Véronique Diéras, Jean-Sébastien Frenel, Séverine Guiu, Marie-Ange Mouret-Reynier, Audrey Mailliez, Jean-Christophe Eymard, and et al. 2023. "Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study" Cancers 15, no. 4: 1191. https://doi.org/10.3390/cancers15041191

François-Martin, H., Lardy-Cléaud, A., Pistilli, B., Levy, C., Diéras, V., Frenel, J.-S., Guiu, S., Mouret-Reynier, M.-A., Mailliez, A., Eymard, J.-C., Petit, T., Ung, M., Desmoulins, I., Augereau, P., Bachelot, T., Uwer, L., Debled, M., Ferrero, J.-M., Clatot, F., ... Cottu, P. (2023). Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study. Cancers, 15(4), 1191. https://doi.org/10.3390/cancers15041191